Lupin logo

LUPIN - Lupin News Story

₹1196.55 -1.8  -0.2%

Last Trade - 11:27am

Sector
Healthcare
Size
Large Cap
Market Cap £5.32bn
Enterprise Value £5.52bn
Revenue £1.49bn
Position in Universe 80th / 3105

BUZZ-Indian pharma stocks fall; report says domestic sales growth at 2-year low

Mon 11th November, 2019 4:18am
BENGALURU, Nov 11 (Reuters) -    ** India's Nifty pharma
index  .NIPHARM  down as much as 1.44% to a two-week low
    ** Pharma stocks Sun Pharmaceutical Industries  SUN.NS 
falls as much as 3.55%, Cipla Ltd  CIPL.NS  down 2.32% and Dr
Reddy's  REDY.NS  loses nearly 1%
    ** Domestic pharma sales growth dipped to a two-year low in
October as the extended monsoon drew to a close, Bloomberg Quint
reports https://www.bloombergquint.com/business/domestic-pharma-sales-growth-falls-to-two-year-low
    ** Volumes contracted 2.7%, with prices rising 5.2%, report
says citing data from market research firm AIOCD AWACS
    ** Indian pharma cos such as Aurobindo Pharma  ARBN.NS  and
Lupin Ltd  LUPN.NS  have already come under U.S. FDA scrutiny
for non-compliance with regulations
    ** The index has fallen over 12% this year as of last close

 (Reporting by Derek Francis in Bengaluru)
 ((derek.francis@thomsonreuters.com; +91-9986311363; Tweet to
@derekfrancis089 LinkedIn: https://www.linkedin.com/in/derek-francis/;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.